GlaxoSmithKline And Merck KGaA Position For The Next Wave In Immuno-Oncology
GlaxoSmithKline And Merck KGaA Position For The Next Wave In Immuno-Oncology.....»»
Merck upgraded to Overweight on immuno-oncology leadership at Morgan Stanley
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BioLineRx expands immuno-oncology collaboration with Merck
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck, Bristol-Myers profits rise on cancer drug sales
Merck & Co Inc and Bristol-Myers Squibb Co posted better-than-expected third quarter profit and raised their 2018 earnings forecasts on Thursday due to strong demand for their rival cancer immuno-oncology treatments......»»
Merck KGaA could receive up to about $4.2 bln in milestone payments as part of GlaxoSmithKline deal
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Merck KGaA to receive upfront payment of about $342.8 mln as part of GlaxoSmithKline collaboration
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
GlaxoSmithKline, Merck KGaA to collaborate on cancer treatments
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
GlaxoSmithKline and Merck KGaA to strike immunotherapy deal worth up to $4.23 billion
U.K.-based GlaxoSmithKline plc a.....»»
GlaxoSmithKline and Merck KGaA strike immunotherapy deal worth up to $4 billion
U.K.-based GlaxoSmithKline Plc  and Germany-based Merck KGaA are entering a partnership to develop and commercialize a therapy for patients with advanced non-small cell lung cancer in a deal worth up to $4.23 billion, the companies announced Tuesday......»»
GSK pays up to $4.2 billion for Merck KGaA cancer immunotherapy
GlaxoSmithKline bolstered its cancer drug development pipeline on Tuesday, agreeing to pay up to 3.7 billion euros ($4.2 billion) to Germany's Merck KGaA for the rights to a next-generation immunotherapy......»»
Why Scopus BioPharma"s Stock Is Surging Today
Scopus BioPharma (NASDAQ:SCPS) shares are trading higher after the company announced the FDA has approved its IND application for CpG-STAT3siRNA, the company's distinctive immuno-oncology RNA therapy for the treatment of multiple cancers. read more.....»»
Merck KGaA price target raised to EUR 155 from EUR 146 at Deutsche Bank
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck KGaA price target raised to EUR 165 from EUR 160 at JPMorgan
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck KGaA raises FY21 net sales view to EUR 18.5B-19.5B
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FDA to discuss whether immuno-oncology drugs with "accelerated" approval should remain on the market
The Food and Drug Administration advisory committee plans to hold a three-day meeting this week to evaluate a type of quicker approval used primarily for immuno-oncology drugs that are thought to help .....»»
GlaxoSmithKline collaboration with Merck would be "win-win," says Citi
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck KGaA downgraded to Reduce from Hold at HSBC on valuation
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck KGaA downgraded to Reduce from Hold at HSBC
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
PRA Health announces Merck KGaA to team on human growth hormone treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
F-star Therapeutics announces third option exercised by Merck KGaA
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pieris amend immuno-oncology pact with Seagen
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»